Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised dose-finding study of DermaPro (DPOCl) vs standard moist wound dressing in non-healing diabetic foot ulcers
2017-004527-67Phase 2Completed
- Sponsor
- DermaTools Biotech
- Start
- Dec 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of DermaPro in diabetic foot ulcer (DFU) (4 arms), sponsored by DermaTools Biotech. Primary endpoint: Relative wound area reduction. Started Dec 2017; status: completed.
02
Drugs
DermaPro
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2017-004527-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004527-67.